| P2093 | author name string | Paul L McCormack | |
| P2860 | cites work | Pharmacokinetics of vilazodone in patients with mild or moderate renal impairment | Q48515921 |
| | Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. | Q48878233 |
| | A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder | Q84833880 |
| | The epidemiology of depression and the evolution of treatment | Q26859199 |
| | Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy | Q28083651 |
| | The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 |
| | Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report | Q29615999 |
| | Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial. | Q30384691 |
| | Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R) | Q33619096 |
| | A review of vilazodone, serotonin, and major depressive disorder | Q33721197 |
| | Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial. | Q34016538 |
| | Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. | Q34088016 |
| | Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis | Q34172837 |
| | Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial | Q35038925 |
| | Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial | Q35038928 |
| | Vilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of action | Q35330385 |
| | Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. | Q36995078 |
| | Augmentation treatment in major depressive disorder: focus on aripiprazole | Q37062552 |
| | Problems associated with long-term treatment with selective serotonin reuptake inhibitors | Q37219382 |
| | Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review | Q37285475 |
| | The Future of Psychopharmacology of Depression | Q37783374 |
| | Antidepressants: current strategies and future opportunities | Q37826211 |
| | Vilazodone: in major depressive disorder | Q37893639 |
| | Efficacy and safety of vilazodone in major depressive disorder: a randomized, double-blind, placebo-controlled trial | Q38419715 |
| | A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder | Q38491814 |
| | Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder | Q40786816 |
| | Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study | Q44742910 |
| | Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation | Q46062036 |
| | Pharmacokinetics and Safety of Vilazodone in Hepatic Impairment | Q48158482 |
| | Influence of CYP3A4 induction/inhibition on the pharmacokinetics of vilazodone in healthy subjects | Q48209574 |
| | Vilazodone lacks proarrhythmogenic potential in healthy participants: a thorough ECG study | Q48483078 |
| P433 | issue | 16 | |
| P921 | main subject | major depressive disorder | Q42844 |
| P304 | page(s) | 1915-1923 | |
| P577 | publication date | 2015-10-26 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Vilazodone: a review in major depressive disorder in adults | |
| P478 | volume | 75 | |